Health News Archive - May 11, 2009
FREMONT, Calif., May 11 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced that Elena Feinstein, M.D., Ph.D., Chief Scientific Officer, presented a study titled, "PF-04523655 (REDD14NP), an siRNA Compound Targeting RTP801, Penetrates Retinal Cells Producing Target Gene Knockdown and Avoiding TLR3 Activation," at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, taking place from May 3-7, 2009, in Fort Lauderdale, Florida.
NUTLEY, N.J., May 11 /PRNewswire/ -- Roche Product Director Kelly Pierson, of Plainfield, N.J., was honored as a 2009 Rising Star by the Healthcare Businesswomen's Association (HBA) at the organization's annual awards luncheon on May 7, 2009 in New York City.
PALO ALTO, Calif. and LONDON, May 11 /PRNewswire/ --Nanosys Inc. and QuantuMDx Group (QMDx) today announced that QMDx has signed a non-exclusive license agreement with Nanosys for several patents and patent applications related to the use of nanowires for biosensors.
KIBBUTZ SHAMIR, Israel, May 11 /PRNewswire-FirstCall/ -- Shamir Optical Industry Ltd.
Product Will Create A Barrier To Block The Attachment Of The Virus To The Nasal Membranes BELGIUM, Wis., May 11 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), an innovative, global wellness solutions company, announces the development of a immunoglobulins based product that can be hand carried and used as needed to form a mechanical barrier to block the attachment of the virus to the nasal membranes. Peter Nash, Ph.D.
People who live in urban areas are more likely to develop late-stage cancer than those who live in suburban and rural areas.
MELBOURNE, Australia, May 11 /PRNewswire/ -- Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY) today announced the signing of a collaborative research, license and commercialisation agreement with Elanco, the animal health division of US pharmaceutical company Eli Lilly and Company.
MIAMI, FL, May 11 /PRNewswire-FirstCall/ - Beeston Enterprises Ltd.
FRANKFURT, Germany, May 11 /PRNewswire/ -- Today, Schlafender Hase is proudly releasing the latest version of the Text Verification Tool. The patent protected Windows application compares manuscript against artwork files, independent of the text layout.
BOSTON, May 11 /PRNewswire/ -- On May 19th, The EntreTech Forum will bring together some of the region's educators, researchers and entrepreneurs to focus on photonics/optics academic/commercial nexus of innovation, and to answer key questions around: understanding the local resource base for photonics-based innovationdistilling the key drivers that define success or failure for early-stage research-driven photonics entrepreneursdefining for the audience what the next great ideas in photonics/optics technology will look like Whether for treating disease, advancing solar energy cells or enhancing semiconductor performance, recent advances in photonics and optics have created myriad opportunities for entrepreneurs to break new ground across a tremendously wide spectrum of commercial activity.
- The deadly nightshade, Atropa Belladonna, which possesses stupefying or poisonous properties.
- A sleeping-potion; a soporific.
- To mutter deliriously.